Concepedia

Narendra K. Vaish

NK

Statistics

Publications

19

Citations

2.1K

H-Index

17

Active since

1992

Affiliations

Max Planck Institute of Experimental Medicine(Current)

Adhera Therapeutics (United States)

Mirna Therapeutics (United States)

Howard Hughes Medical Institute

Boston College

Narendra K. Vaish is an author at Max Planck Institute of Experimental Medicine specializing in life sciences, molecular biology, and biochemistry.

Publications per year

1992–2011

19

Publications

19

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Jennifer A. Lockridge, Lucinda Shaw, Karin S. Blanchard et al. · Nature Biotechnology · 2005 · 1.2K citations

, , +12

Halo- and selenolactonisation: the two major strategies for cyclofunctionalisation

Subramania Ranganathan, K.M. Muraleedharan, Narendra K. Vaish et al. · Tetrahedron · 2004 · 248 citations

, , +6

Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs

Narendra K. Vaish, Feng Chen, Shaguna Seth et al. · Nucleic Acids Research · 2010 · 109 citations · Full text

, , +15

A Novel, Modification-Dependent ATP-Binding Aptamer Selected from an RNA Library Incorporating a Cationic Functionality

Narendra K. Vaish, Rosa Larralde, Andrew W. Fraley et al. · Biochemistry · 2003 · 75 citations

, , +17

Expanding the structural and functional diversity of RNA: analog uridine triphosphates as candidates for in vitro selection of nucleic acids

Narendra K. Vaish · Nucleic Acids Research · 2000 · 60 citations

, , +11

1–5 of 19